5-LOX |
5-lipoxygenase |
AD |
Alzheimer’s disease |
ADAS-Cog |
Alzheimer’s disease assessment scale–cognitive subscale |
ADCS |
Activities of daily living scales |
ALA |
α linolenic acid |
ApoE |
apolipoprotein E |
APP |
amyloid precursor protein |
ARA |
arachidonic acid |
Aβ |
amyloid beta peptide |
BADLS |
Bristol’s activities of daily living scale |
BASDEC |
brief assessment schedule depression cards |
BBB |
blood–brain barrier |
BDI |
Beck depression inventory scale |
CDR |
clinical dementia rating scale |
CGI |
clinical global impression scale |
CIBIC-Plus |
clinician interview-based impression of change, plus carer interview |
COX |
cyclooxygenase |
cPLA2 |
cytosolic calcium-dependent phospholipase A2 |
CSF |
cerebrospinal fluid |
DHA |
docosahexaenoic acid |
DHA-FFA |
free nonesterified form docosahexaenoic acid |
DSM-IV |
Diagnostic and Statistical Manual of Mental Disorders, fourth edition |
EPA |
eicosapentaenoic acid |
FABPs |
fatty acid binding proteins |
HDRS |
Hamilton depression rating scale |
hs-CRP |
C-reactive protein |
HVLT-R |
Hopkins verbal learning test–revised |
iPLA2 |
cytosolic calcium-independent phospholipase A2 |
LA |
linoleic acid |
LXA4
|
lipoxin A4
|
MADRS |
Montgomery–Åsberg depression rating scale |
MMSE |
mini-mental state examination |
MUFAs |
monounsaturated fatty acids |
NPI |
Neuropsychiatric Inventory |
NTB |
neuropsychological test battery |
PD |
Parkinson’s disease |
PKC |
protein kinase C |
PLA2 |
phospholipase A2 |
PUFAs |
omega-3 polyunsaturated fatty acids |
sPLA2 |
secretory phospholipase A2 |
RvD1 |
resolvin D1 |
TAC |
total antioxidant capacity |
UPDRS |
unified Parkinson’s disease rating scale |